The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...
A collaboration between a rural, urgent care center network and diagnostics company may be laying the groundwork for speeding ...
A multicenter cohort study explores how the timing of ASM withdrawal after epilepsy surgery may influence seizure relapse and ...
Autism is diagnosed earlier in males, but diagnoses in females rise with age, narrowing the gender gap and leaving lifetime ...
Studying disease amid the stress of medical school can make every headache a tumor and every muscle twitch ALS. Welcome to ...
Higher serum levels of interferon alfa, but not interferon gamma, are tied to worse disease activity in patients with ...
New research links consumption of ultraprocessed foods to earlier death in cancer survivors — but caveats abound.
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis ...
Duloxetine 120 mg offers the greatest economic value for treating moderate-to-severe fibromyalgia, followed by pregabalin 450 ...
The FDA has outlined numerous concerns about the sale and use of unapproved GLP-1 drugs for weight loss. “FDA is aware that ...
Results from a new small study suggest people aged 50 and older with MS who want to discontinue disease-modifying therapy can do so with cladribine with minimal risk for relapse.
International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results